Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × Methylphenidate × Clear all

Phase

Status

Sponsor Class

OTHER 26 INDUSTRY 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiotherapy 299 Cisplatin 263 Cyclophosphamide 229 Doxorubicin 176 Paclitaxel 166 Vincristine 160 Carboplatin 149 Filgrastim 139 Etoposide 139 Gemcitabine 118 Fluorouracil 113 Docetaxel 112 Methotrexate 106 Dexamethasone 106 Cytarabine 106 Prednisone 91 Leucovorin 90 Granulocyte Colony-Stimulating Factor 74 Specimen Handling 64 Magnetic Resonance Spectroscopy 61 Capecitabine 59 Irinotecan 58 Radiation 53 Ifosfamide 51 Oxaliplatin 48 Daunorubicin 48 Temozolomide 47 Platinum 47 Peripheral Blood Stem Cell Transplantation 47 Radiotherapy, Conformal 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003266 2023-06-18

Methylphenidate in Treating Patients With Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡